Immunological Mechanisms in Allergic Conjunctivitis

Allergic conjunctivitis arises from a hypersensitivity reaction localised to the conjunctival mucosa and associated ocular surface. Sensitisation begins when allergens penetrate the epithelium and are captured by antigen-presenting cells, which prime naive T cells towards a type 2 helper (Th2) phenotype. Subsequent allergen exposure triggers cross-linking of IgE bound to mast cells, inducing degranulation and rapid release of histamine, proteases and lipid mediators. These early-phase events elicit vasodilation, increased vascular permeability and itching. In the late phase, Th2 cytokines such as interleukins 4, 5 and 13 recruit eosinophils and basophils, perpetuating inflammation through cytotoxic protein release and further mediator production. Innate immune pathways also contribute: epithelial cells produce alarmins (for example IL-33 and thymic stromal lymphopoietin) that activate type 2 innate lymphoid cells and basophils, amplifying Th2 bias independent of adaptive priming. Toll-like receptor signalling on epithelial and immune cells can recognise environmental components, linking innate detection with type 2 responses via MyD88-dependent pathways. The cumulative effect is chronic conjunctival inflammation, tissue remodelling and potential impairment of tear film homeostasis. Understanding these intersecting adaptive and innate cascades has guided the development of targeted therapies, ranging from antihistamines and mast cell stabilisers to biologics that neutralise key cytokines or block alarmin receptors.

Research from Nature Portfolio

Recent studies have uncovered how environmental allergens directly engage innate sensors on the ocular surface to initiate and sustain allergic inflammation. Work on pollen-induced conjunctivitis has shown that allergenic particles activate Toll-like receptor 4 on corneal and conjunctival cells, triggering an NF-κB-driven cascade that elevates IL-33 expression. Binding of IL-33 to its receptor ST2 on group 2 innate lymphoid cells and Th2 lymphocytes promotes robust production of IL-4, IL-5 and IL-13, driving both immediate and delayed allergic responses. Genetic ablation of TLR4 or key adaptor molecules in this pathway markedly attenuates clinical signs, epithelial cytokine signals and eosinophil recruitment in murine models, highlighting a pivotal mechanism that bridges innate recognition with type 2 immunity.

Immunological Mechanisms in Allergic Conjunctivitis publication trend

The graph below shows the total number of articles in immunological mechanisms in allergic conjunctivitis across all publications each year (not limited to Nature Index journals).

Technical terms

Toll-like receptor 4 (TLR4): a pattern-recognition receptor on epithelial and immune cells that detects environmental stimuli and initiates innate immune signalling.

IL-33: an epithelial-derived alarmin cytokine that binds the ST2 receptor to activate type 2 immune responses.

Th2 cytokines: interleukins such as IL-4, IL-5 and IL-13 produced by type 2 helper T cells and innate lymphoid cells, orchestrating allergic inflammation.

Mast cell degranulation: the rapid release of histamine, proteases and lipid mediators from mast cells upon allergen-mediated IgE cross-linking.

Eosinophils: granulocytic leukocytes recruited by Th2 signals that release cytotoxic proteins and cytokines at sites of allergic inflammation.

Alarmins (DAMPs): endogenous molecules released by stressed or damaged cells that activate innate immune pathways.

Proteomics: the large-scale analysis of protein expression and modifications, often using mass spectrometry, to identify biomarkers and molecular targets.

References

1. Alleviation of allergic conjunctivitis by (±)5(6)-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid in mice. Frontiers in Pharmacology (2023).
2. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation. Scientific Reports (2016).
3. Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases. Cells (2022).
4. A Review of Emerging Tear Proteomics Research on the Ocular Surface in Ocular Allergy. Biology (2022).